Gelteq is trading 10.10% lower at $0.55 after closing at $0.61 on September 22, 2026; no clear company-specific catalyst has been identified.

  • Gelteq’s investor-relations page showed no September 22 announcement; the latest surfaced financing news dates to May.
  • The broader biotech sector was higher pre-market, so sector strength does not explain the decline.
  • Confidence remains low pending possible delayed filings or news.